Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease

Area of Science:

• Neurology
• Speech-Language Pathology
• Pharmacology

Background:

• Levodopa medication impacts motor speech in Parkinson's disease (PD).
• The dynamic changes in speech characteristics throughout a levodopa cycle in advanced PD remain under-investigated.
• Understanding these fluctuations is key for effective speech interventions.

Purpose of the Study:

• To sequentially analyze respiratory, articulatory, and phonatory speech changes during a levodopa cycle in advanced Parkinson's disease.
• To correlate these speech changes with motor performance fluctuations.
• To establish the necessity of comprehensive, individualized assessments.

Main Methods:

• Spirometry, acoustic analysis, and motor speech assessments were employed.
• Seven patients with advanced PD were evaluated at 15-minute intervals before and after levodopa intake.
• Repeated measures ANOVA and non-parametric analyses were used for data interpretation.

Main Results:

• Significant alterations were observed in motor function, vital capacity, and diadochokinetic rate variability.
• A discernible trend indicated changes in voice shimmer and the first formant frequency.
• Marked inter-individual variability in speech parameter responses to levodopa was evident.

Conclusions:

• Single-point assessments of speech characteristics post-levodopa are insufficient for advanced PD patients.
• A thorough, individualized evaluation across the entire levodopa cycle is essential.
• This comprehensive approach is recommended before commencing speech-language pathology interventions.